Skip to main content

Table 5 Longitudinal comparison of MMSE scores in the two groups

From: Effect of long-term adjuvant temozolomide chemotherapy on primary glioblastoma patient survival

MMSE score

GroupA(n = 27)

Mean ± SD

Group B (n = 26)

Mean ± SD

P value

T1

21.59 ± 4.19

21.65 ± 4.56

0.960

T2

19.96 ± 4.55

19.53 ± 4.36

0.730

T3

24.77 ± 2.76

24.84 ± 2.98

0.931

T4

20.37 ± 5.83

23.84 ± 4.49

0.019